Dag 1 av den 77. verdenshelseforsamlingen (27. mai)

Den syttisjuende verdenshelseforsamlingen (WHA) åpner i Palais des Nations i Genève klokken 09.00 i morgen, 27. mai. På sin første dag vil WHA møtes i plenum, generalkomité og komité A. Det detaljerte arbeidsprogrammet finnes i Daily Journal N°1 , tilgjengelig på seks språk i FN (FN).

Simultantolking vil være tilgjengelig på arabisk, kinesisk, engelsk, fransk, russisk og spansk. Den direktesendte webcasten av saksgangen kan nås her, 

Consolidated report by the Director-General1
PILLAR 1: ONE BILLION MORE PEOPLE BENEFITING FROM UNIVERSAL
HEALTH COVERAGE

11. Review of and update on matters considered by the Executive Board
    11.1 Universal health coverage
12. The Executive Board at its 154th session noted the report on universal health coverage.2
    It adopted
    decision EB154(6) on development of a global strategy and action plan for integrated emergency, critical
    and operative care, 2026–2035, in which it recommended to the Health Assembly the development of
    such a strategy for consideration by the Seventy-ninth World Health Assembly, through the Executive
    Board at its 158th session. It also considered the text of a draft resolution introduced by Member States
    on social participation for universal health coverage, health and well-being. The Board agreed that
    consultations on the draft resolution would continue during the intersessional period. In the discussions,
    Board members acknowledged the declaration of the United Nations General Assembly on universal
    health coverage and the central role of reorienting health systems towards a primary health care approach
    in achieving universal health coverage. They affirmed that universal health coverage and strong health
    systems should underpin the draft fourteenth general programme of work.
    11.2 Follow-up to the political declaration of the third high-level meeting of the
    General Assembly on the prevention and control of non-communicable diseases
13. The Executive Board at its 154th session noted the report on the prevention and management of
    noncommunicable diseases, promotion of mental health and well-being, and treatment and care of
    mental health conditions.
    3
    It adopted decision EB154(7) on increasing availability, ethical access and
    oversight of transplantation of human cells, tissues and organs, in which it recommended to the Health
    Assembly, inter alia, the development of a global strategy on donation and transplantation for
    consideration by the Seventy-ninth World Health Assembly, through the Executive Board at its
    158th session. It also considered the text of a draft resolution introduced by Member States on
    strengthening mental health and psychosocial support before, during and after armed conflicts, natural
    disasters and health and other emergencies. The Board agreed that consultations on the draft resolution
    1
    In the present document the texts under each agenda item should be read in conjunction with the corresponding
    reports considered by the Executive Board at its 154th session. The summary records of those sessions are available at the
    following link: http://apps.who.int/gb/or/.
    2 Document EB154/6; see also the summary records of the Executive Board at its 154th session, fifth meeting and
    sixth meeting, section 1.
    3 Document EB154/7; see also the summary records of the Executive Board at its 154th session, sixth meeting,
    section 2 and seventh meeting, section 1.
    A77/4
    2
    would continue during the intersessional period. In the discussions, Board members highlighted the need
    to include noncommunicable diseases and mental health in primary health care and universal health
    coverage. They welcomed the global oral health action plan 2023–2030 and the planned development
    of a global status report on cancer 2025 and called for regular information updates to support Member
    States in preparing for the fourth high-level meeting of the United Nations General Assembly on the
    prevention and control of non-communicable diseases.
    11.3 Draft global action plan for infection prevention and control
14. The Executive Board at its 154th session noted the report concerning the draft global action plan
    for infection prevention and control.1
    It adopted decision EB154(8) in which it recommended to the
    Health Assembly the adoption of the global action plan and monitoring framework on infection
    prevention and control, 2024–2030.
    11.4 Immunization Agenda 2030
15. The Executive Board at its 154th session noted the report on the Immunization Agenda 2030.2
    In
    the discussions, Board members voiced support for the shared action agenda and its six short-term
    priority areas, and especially the “Big Catch-Up” initiative. They expressed concern over the rising
    number of outbreaks, particularly measles, and underscored the need for recovery of coverage levels
    and catch-up of children missed during the COVID-19 pandemic.
    11.5 End TB Strategy
16. The Executive Board at its 154th session noted the report on the End TB Strategy.3
    In the
    discussions, Board members expressed strong support for WHO’s leadership in the fight against
    tuberculosis. They highlighted the need for increased investment, multisectoral collaboration, equitable
    access to tuberculosis services, and research and innovation in order to achieve the goals and targets
    agreed in the End TB Strategy and the 2023 political declaration of the high-level meeting of the General
    Assembly on the fight against tuberculosis.
    11.6 Road map for neglected tropical diseases 2021–2030
17. The Executive Board at its 154th session noted the report on the road map for neglected tropical
    diseases 2021–2030.4
    In the discussions, Board members acknowledged the protracted impact of the
    COVID-19 pandemic on the financing and performance of health programmes. They noted the need to
    sustain innovation for medicines, diagnostics and strategic approaches, notably to tackle threats such as
    climate change, which can have a major impact on the epidemiology of neglected tropical diseases, and
    acknowledged that challenges in accessing treatments persisted. Board members noted the progress
    1 Documents EB154/8 and EB154/8 Add.1; see also the summary records of the Executive Board at its 154th session,
    seventh meeting, section 2.
    2 Document EB154/9; see also the summary records of the Executive Board at its 154th session, eleventh meeting,
    section 2. An overview of the status of immunization, including preliminary data from 2023, is provided in the IA2030
    Global Report 2023, to be available at the following link: https://www.immunizationagenda2030.org/ia2030-annual-reports.
    3 Document EB154/10; see also the summary records of the Executive Board at its 154th session, eleventh meeting,
    section 3.
    4 Document EB154/11; see also the summary records of the Executive Board at its 154th session, eleventh meeting,
    section 4, and twelfth meeting, section 2.
    A77/4
    3
    made,1
    including the acknowledgement by WHO of the 50th country to eliminate one neglected tropical
    disease, and the inclusion of noma in this group of conditions.
    11.7 Acceleration towards the Sustainable Development Goal targets for maternal
    health and child mortality
18. The Executive Board at its 154th session noted the report on acceleration towards the Sustainable
    Development Goal targets for maternal and child mortality.
    2
    It considered the text of a draft resolution
    introduced by Member States on accelerating progress towards reducing maternal, newborn and child
    mortality in order to achieve Sustainable Development Goal targets 3.1 and 3.2. The Board agreed that
    consultations on the draft resolution would continue during the intersessional period. In the discussions,
    Board members expressed concern that many countries were not on track to achieve the targets for
    reducing maternal and child mortality by the year 2030.
    PILLAR 2: ONE BILLION MORE PEOPLE BETTER PROTECTED FROM HEALTH
    EMERGENCIES
19. Review of and update on matters considered by the Executive Board
    14.1 WHO’s work in health emergencies
20. The Executive Board at its 154th session noted the reports on public health emergencies:
    preparedness and response; strengthening the global architecture for health emergency preparedness,
    prevention, and response and resilience; and health conditions in the occupied Palestinian territory,
    including east Jerusalem.3
    It adopted decisions EB154(9) on the universal health and preparedness
    review and EB154(10) on strengthening laboratory biological risk management. It also adopted
    resolution EB154.R7 on health conditions in the occupied Palestine territory, including east Jerusalem.
    It also considered the text of a draft resolution introduced by Member States on strengthening health
    emergency preparedness for disasters resulting from natural hazards. The Board agreed that
    consultations on the draft resolution would continue during the intersessional period. Separate reports
    on WHO’s work in health emergencies and on health conditions in the occupied Palestinian territory,
    including east Jerusalem, will be considered by the Health Assembly under this agenda item.
    14.3 Global Health and Peace Initiative
21. The Executive Board at its 154th session noted the report on the Global Health and Peace
    Initiative.4
    It also adopted decision EB154(11), in which it recommended to the Health Assembly, inter
    alia, continued support for evidence gathering, communication and dialogue as part of the consultative
    process of strengthening the Roadmap for the Global Health and Peace Initiative and submission of a
    status report on the Roadmap to the Health Assembly in 2029. In the discussions, Board members
    emphasized the importance of protecting health care infrastructure and workers in conflict-affected areas.
    1 A detailed progress update can be found in the Global report on neglected tropical diseases 2024, which will be
    available at the following link: https://www.who.int/teams/control-of-neglected-tropical-diseases/overview.
    2 Document EB154/12; see also the summary records of the Executive Board at its 154th session, twelfth meeting,
    section 3.
    3 Documents EB154/14, EB154/15 and EB154/51; see also the summary records of the Executive Board at its
    154th session, eighth meeting, section 2 and ninth meeting, section 1.
    4 Document EB154/17; see also the summary records of the Executive Board at its 154th session, tenth meeting,
    section 1.
    A77/4
    4
    14.4 Poliomyelitis

• Poliomyelitis eradication

11. The Executive Board at its 154th session noted the report on poliomyelitis eradication.1
    In the
    discussions, Board members highlighted the need for robust surveillance and for targeted measures to
    reach all zero-dose children in critical areas.

• Polio transition planning and polio post-certification

11. The Executive Board at its 154th session noted the report on polio transition planning and polio
    post-certification.2
    In the discussions, Board members emphasized the importance of taking the steps
    necessary to prepare for a polio-free world, including strengthening immunization, surveillance,
    outbreak preparedness and response and poliovirus containment.
    14.5 Smallpox eradication: destruction of variola virus stocks
12. The Executive Board at its 154th session noted the report on smallpox eradication: destruction of
    variola virus stocks.3
    In the discussions, Board members suggested that the Secretariat should continue
    to share information on the state of variola virus and ensure regular inspections of the WHO
    collaborating centre repository laboratories. They welcomed the information provided on the status of
    the continuing multicountry mpox outbreak for which smallpox countermeasures had been deployed in
    many countries. In advance of the Seventy-seventh World Health Assembly, Member States were
    invited to consider whether and how research on orthopoxviruses and smallpox should continue.
    PILLAR 3: ONE BILLION MORE PEOPLE ENJOYING BETTER HEALTH AND
    WELL-BEING
13. Review of and update on matters considered by the Executive Board
    15.1 Social determinants of health
14. The Executive Board at its 154th session noted the report on progress of the World Report on
    Social Determinants of Health Equity.4
    In the discussions, Board members drew attention to several
    promising initiatives to address social determinants of health, while expressing concerns about the slow
    progress in implementing the 2008 recommendations of the WHO Commission on Social Determinants
    of Health. They provided guidance for the finalization of the forthcoming world report.
    1 Document EB154/18; see also the summary records of the Executive Board at its 154th session, tenth meeting,
    section 2.
    2 Document EB154/19; see also the summary records of the Executive Board at its 154th session, tenth meeting,
    section 2.
    3 Document EB154/20; see also the summary records of the Executive Board at its 154th session, eleventh meeting,
    section 1.
    4 Document EB154/21; see also the summary records of the Executive Board at its 154th session, thirteenth meeting,
    section 3.
    A77/4
    5
    15.2 Maternal, infant and young child nutrition
15. The Executive Board at its 154th session noted the biennial report on the comprehensive
    implementation plan on maternal, infant and young child nutrition,1
    including the guidance on regulatory
    measures aimed at restricting digital marketing of breast-milk substitutes.
    2
    In the discussions, Board
    members called on the Secretariat to hold further consultations on the implementation of the guidance. They
    also requested the Secretariat to hold consultations on the options for extending global nutrition targets
    and the comprehensive implementation plan on maternal, infant and young child nutrition after 2025.
    15.3 Well-being and health promotion
16. The Executive Board at its 154th session noted the report on well-being and health promotion.3
    It
    also adopted decision EB154(13) on strengthening health and well-being through sport events. In the
    discussions, Board members welcomed the progress in implementing the global framework on
    well-being and health promotion, reiterated the need to integrate subjective and societal well-being into
    public health and highlighted the importance of social connection for the health and well-being of
    individuals.
    15.4 Climate change, pollution and health

• Impact of chemicals, waste and pollution on human health

11. The Executive Board at its 154th session noted the report on the impact of chemicals, waste and
    pollution on human health.4
    In the discussions, Board members expressed support for the exploration of
    options described in the report for future involvement of WHO in the intergovernmental science-policy
    panel to contribute further to the sound management of chemicals, waste and prevent pollution being
    negotiated by the ad hoc open-ended working group convened by the United Nations Environment
    Programme. Board members also underscored the importance of including health aspects in negotiations
    for the new legally binding instrument to end plastic pollution.

• Climate change and health

11. The Executive Board at its 154th session noted the report on climate change and health5
    and
    considered the text of a draft resolution introduced by Member States on the same topic. In the
    discussions, Board members observed that the climate crisis was a health crisis and welcomed the
    Secretariat’s efforts to improve Member States’ capacities to respond to the impacts of climate change
    on health while promoting low carbon societies and health systems. The Board agreed that consultations
    on the draft resolution would continue during the intersessional period.
    1 Document EB154/22; see also the summary records of the Executive Board at its 154th session, fourteenth meeting,
    section 1.
    2 Guidance on regulatory measures aimed at restricting digital marketing of breast-milk substitutes. Geneva: World
    Health Organization; 2023 (https://iris.who.int/handle/10665/374182, accessed 23 February 2024).
    3 Document EB154/23; see also the summary records of the Executive Board at its 154th session, fourteenth meeting,
    section 2.
    4 Document EB154/24; see also the summary records of the Executive Board at its 154th session, fifteenth meeting,
    section 1.
    5 Document EB154/25; see also the summary records of the Executive Board at its 154th session, fifteenth meeting,
    section 1.
    A77/4
    6
    15.5 Economics and health for all
12. The Executive Board at its 154th session noted the report on economics and health for all1
    and
    considered the text of a draft resolution introduced by Member States on the same topic. In the
    discussions, Board members recognized the close two-way relationship between economic development
    and health and emphasized the importance of a multisectoral Health in All Policies approach. They
    highlighted the need to maximize the public value of investments in health and to counterbalance
    commercial influence that is not aligned with health for all. The Board agreed that consultations on the
    draft resolution would continue during the intersessional period.
    PILLAR 4: MORE EFFECTIVE AND EFFICIENT WHO PROVIDING BETTER
    SUPPORT TO COUNTRIES
13. Staffing matters
    23.2 Amendments to the Staff Regulations and Staff Rules
14. The Executive Board at its 154th session noted the report on amendments to the Staff Regulations
    and Staff Rules.2
    It adopted resolution EB154.R8 in which it confirmed amendments to the Staff Rules
    concerning the standards of conduct for staff members, promotion, Global Board of Appeal and staff in
    posts subject to local recruitment. It also adopted resolution EB154.R9, in which it recommended to the
    Health Assembly the adoption of amendments to Staff Regulation 6.2 on parental leave, to take effect
    from 1 January 2024. The proposed amendments would align this Regulation with Staff Rule 760,
    amendments to which were confirmed by the Executive Board at its 152nd session in February 2023.3
    23.3 Report of the International Civil Service Commission
15. The Executive Board at its 154th session noted the report of the International Civil Service
    Commission.4
16. Management, legal and governance matters
    24.1 Prevention of sexual exploitation, abuse and harassment
17. The Executive Board at its 154th session noted the report on prevention of sexual exploitation,
    abuse and harassment.5
    In the discussions, Board members expressed strong support for the concerted
    approach being taken by WHO to address sexual exploitation, abuse and harassment among its personnel
    and implementing partners. They requested the Secretariat to submit proposals for mechanisms to ensure
    full and sustainable funding of activities to prevent sexual misconduct in emergencies, and for defining
    Member States’ accountability to ensure prevention of and response to sexual misconduct in line with
    WHO’s own accountability.
    1 Document EB154/26; see also the summary records of the Executive Board at its 154th session, fifteenth meeting,
    section 2.
    2 Document EB154/48 Rev.1; see also the summary records of the Executive Board at its 154th session, sixteenth
    meeting, section 2.
    3 See resolution EB152.R6.
    4 Document EB154/49; see also the summary records of the Executive Board at its 154th session, sixteenth meeting,
    section 2.
    5 Document EB154/30; see also the summary records of the Executive Board at its 154th session, fourth meeting,
    section 1.
    A77/4
    7
    ACTION BY THE HEALTH ASSEMBLY
18. The Health Assembly is invited to note this report. The Health Assembly is further invited:

• under item 11.1, to adopt the decision recommended by the Executive Board in decision
  EB154(6);
• under item 11.2, to adopt the resolution recommended by the Executive Board in decision
  EB154(7);
• under item 11.3, to adopt the decision recommended by the Executive Board in decision
  EB154(8);
• under item 14.1, to adopt the decision recommended by the Executive Board in decision
  EB154(9), and the resolutions recommended by the Executive Board in decision EB154(10)
  and resolution EB154.R7;
• under item 14.3, to adopt the resolution recommended by the Executive Board in decision
  EB154(11);
• under item 15.3, to adopt the resolution recommended by the Executive Board in decision
  EB154(13);
• under item 23.2, to adopt the resolution recommended by the Executive Board in resolution
  EB154.R9.

og den foreløpige talerlisten er tilgjengelig her . Arbeidstiden til Helseforsamlingen er fra 09.00 til 12.00 og 14.30 til 17.30 CEST.

WHA77 – Online inskripsjon for medlemsland som ber om å avgi uttalelse under
punkt 3 i den foreløpige dagsordenen for den sytti-syvende verdenshelseforsamlingen

Merk: Vær oppmerksom på at uttalelser i henhold til vanlig praksis
av gjester på høyt nivå av generaldirektøren og regionale uttalelser vil bli levert før nasjonale uttalelser

Dagens høydepunkter:

• Valg av president og embetsmenn i forsamlingen
• Velkomst på høyt nivå og utdeling av Health Leaders’ Awards (omtrent 09.40 CEST)
• Tale av Dr Tedros Adhanom Ghebreyesus , WHOs generaldirektør (omtrent 14.30 CEST)
• Behandling av utkastet til fjortende generelle arbeidsprogram ( GPW14 ), 2025-2028 ( A77/16 )
• Finansiering og gjennomføring av Programbudsjettet 2024-2025 ( A77/14 og A77/15 ) og WHOs investeringsrunde ( A77/17 , EB154/2024/REC/1, vedtak EB154(1)

Under velkomstsegmentet på høyt nivå vil HE Elisabeth Baume-Schneider , forbundsråd i det sveitsiske konføderasjonen tale forsamlingen på vegne av vertslandet. Delegatene vil også høre fra den spesielle æresgjesten HE Mohamed El Ghazouani , president i Mauritania og leder av Den afrikanske union og Thomas Bach , president for Den internasjonale olympiske komité. HE António Guterres , FNs generalsekretær, HE Anwar bin Ibrahim , statsminister i Malaysia, HE Srettha Thavisin , statsminister i Kongeriket Thailand og HE Ursula Von der Leyen , president for EU-kommisjonen vil levere videouttalelser. Den detaljerte visningen finner du i denne mediemeldingen .

På slutten av velkomsten på høyt nivå vil Dr Tedros dele ut generaldirektørens pris for global helse til to anerkjente forskere og professorer, i tillegg til HE Mia Mottley , statsminister på Barbados, som mottok sin pris ved lanseringen av WHO Investment Runde arrangement søndag 26. mai.

Om morgenen vil helseforsamlingen velge sin hovedkomité, som vil møtes i privat regi for blant annet å vedta dagsorden og arbeidsprogram for WHA77, diskutere innsending av eventuelle supplerende agendapunkter til forsamlingen, og fordele agendapunkter til forsamlingen. hovedutvalgene.

Medieressurser

• Foreløpig arbeidsprogram for WHA77
• WHA77 live webcast og den foreløpige listen over høyttalere
• WHOs generaldirektørs åpningstale på den ^77. verdenshelseforsamlingen vil bli sendt til media og lagt ut her etter levering
• Kringkastet videomateriale og annet presseinnhold vil bli oppdatert via Canto. For spørsmål knyttet til direkte videooverføring kontakt tvstudio@who.int
• WHA77-bilder kan nås og lastes ned uten forutgående registrering. Nye bilder vil bli lagt til daglig : https://photos.hq.who.int/galleries/1764/wha77-27-may-to-1-june-2024- . For spørsmål knyttet til fotografering kontakt photos@who.int
• WHA77-dokumenter (på denne siden kan du også finne Daily Journal med et detaljert arbeidsprogram for dagen)
• WHA77 Daglige oppdateringer inneholder en oppsummering av diskusjonene i helseforsamlingen og sendes på slutten av dagen
• Medieakkreditering for WHA77 håndteres av FNs kontor i Genève, vennligst be om akkreditering via Indico
• Kalender for sidebegivenheter (vedlikeholdes av FN-stiftelsen)